Single-cell resolution
We harness the richness of single-cell multiomics data to explain complex biological processes
Artificial Intelligence
We apply AI for unbiased, innovative, sensitive, and integrative multiomics data analysis
Biomarker discovery
We deliver translatable biomarker signatures related to therapy response, diagnosis or disease severity
We ensure the success of your project
Rapid biomarker discovery
End-to-end single-cell data generation through to data insights
Unbiased data interpretation
We reach high discovery success rates with our best-in-class AI algorithm, using a cluster-free data analysis approach
Indication- and cell type-agnostic analysis
We ensure that our solution fits your needs
Prof. Dr Michael Mueller
Leading Clinician in Women’s Health & Scientific Advisor
Pascal Koenig
Entrepreneur & Chairman of the Board of Directors
Dominique Mégret
Scailyte Board of Directors & Head Swisscom Ventures
Prof. Woong-Yang Park
Founder and CEO of Geninus
Recent News
PAPER: Mapping single-cell data - Nature Biotech
Large single-cell atlases are now routinely generated to serve as references for the analysis of sma
Recent News
Scailyte Closes Financing Round and Onboards Top Biotech Leaders
Scailyte has successfully finished the first closing of their series A. Two new investors joined the
Recent News
Scailyte Quarterly Update December 2021
December 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.
Recent News
VACANCY: Regulatory Affairs / Quality Management Specialist
We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu
Recent News
Why single-cell technologies are vital for Endometriosis research webinar
Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th
Recent News
Single-Cell Discovery Grant in Oncology and Immunology
Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo
Recent News
Scailyte and Lexogen create a joint biomarker discovery workflow
Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution
Recent News
Scailyte Quarterly Update June 2021
June 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.
Recent News
PAPER: Mapping single-cell data - Nature Biotech
Large single-cell atlases are now routinely generated to serve as references for the analysis of sma
Scailyte Closes Financing Round and Onboards Top Biotech Leaders
Scailyte has successfully finished the first closing of their series A. Two new investors joined the
Recent News
Scailyte Quarterly Update December 2021
December 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.
VACANCY: Regulatory Affairs / Quality Management Specialist
We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu
Recent News
Why single-cell technologies are vital for Endometriosis research webinar
Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th
Single-Cell Discovery Grant in Oncology and Immunology
Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo
Recent News
Scailyte and Lexogen create a joint biomarker discovery workflow
Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution
Scailyte Quarterly Update June 2021
June 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.